A Phase 2 Study of Sitravatinib in Combination with PD-(L)1 Checkpoint Inhibitor Regimens in Patients with Advanced or Metastatic Urothelial Carcinoma

A Rollover Study to Follow the Durability of Response for Patients from Study UT001 (Formerly TC-UT-03, Post-marketing Commitment) and Study TC-BC-12

Randomized Phase 2 Trial of Maintenance Oral Etoposide or Observation Following High-dose Chemotherapy for Relapsed Metastatic Germ-Cell Tumor